SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-070459
Filing Date
2021-05-21
Accepted
2021-05-21 16:00:42
Documents
12
Period of Report
2021-05-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2117206d1_8k.htm   iXBRL 8-K 41799
  Complete submission text file 0001104659-21-070459.txt   215032

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rigl-20210518.xsd EX-101.SCH 3178
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rigl-20210518_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rigl-20210518_pre.xml EX-101.PRE 22705
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2117206d1_8k_htm.xml XML 3510
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29889 | Film No.: 21948900
SIC: 2834 Pharmaceutical Preparations